Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties

Published:2023-06-08 Issue:1 Volume:15 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Elsayed Abdullah¹²^ORCID,Pellegrino Christian³^ORCID,Plüss Louis¹²,Peissert Frederik¹,Benz Ramon²,Ulrich Franziska²,Thorhallsdottir Gudrun¹²^ORCID,Plaza Sheila Dakhel¹,Villa Alessandra¹,Mock Jacqueline¹^ORCID,Puca Emanuele¹^ORCID,De Luca Roberto¹^ORCID,Manz Markus G.³^ORCID,Halin Cornelia²^ORCID,Neri Dario¹²⁴^ORCID

Affiliation:

1. Philochem AG, Libernstrasse 3, Otelfingen, Switzerland

2. Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland

3. Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

4. Philogen SpA, Siena (S), Italy

Funder

The in vivo safety study was partially supported by Innosuisse Innovation

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2220839

Reference61 articles.

1. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.

2. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins

3. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains

4. T-cell antigen receptor genes and T-cell recognition

5. Understanding the drivers of MHC restriction of T cell receptors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer;Molecular Cancer Therapeutics;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3